The decrease in hepatic IGF-I gene expression in arthritis rats is not associated with modifications in hepatic GH receptor mRNA

European Journal of Endocrinology

Volumn 144, Issue 5, 2001, Pages 529-534

  Lopez Calderon A ^a   Ibanez De Caceres I ^a   Soto, L ^a   Priego, T ^a   Martin A I ^b   Villanua M A ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSIDAD EUROPEA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; GROWTH HORMONE RECEPTOR; HUMAN GROWTH HORMONE; MESSENGER RNA; SODIUM CHLORIDE; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; CATABOLISM; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE EXPRESSION; HORMONE RESISTANCE; HORMONE SENSITIVITY; HYPERMETABOLISM; INFLAMMATION; LIVER LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN SYNTHESIS; RAT; WEIGHT GAIN;

EID: 0342467882     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1440529     Document Type: Article

References (34)

1. Roubenoff R, Freeman LM, Smith DE, Abad LW, Dinarello CA & Kehayias JJ. Adjuvant arthritis as a model of inflammatory cachexia. Arthritis and Rheumatism 1997 40 534-539.
2. Harbuz MS & Lightman SL. Stress and hypothalamic-pituitary-adrenal axis: acute, chronic and immunological activation. Journal of Endocrinology 1992 134 327-339.
3. Fan J, Char D, Bagby GJ, Gelato MC & Lang CH. Regulation of insulin-like growth factor-I (IGF-I) and IGF-binding proteins by tumor necrosis factor. American Journal of Physiology 1995 269 1204-1212.
4. Soto L, Martín AI, Millán S, Vara E & López-Calderón A. Effects of endotoxin lipopolysaccharide administration on the somatotropic axis. Journal of Endocrinology 1998 159 239-246.
5. Neidhart M & Flückiger EW. Hyperprolactinaemia in hypophysectomized or intact male rats and the development of adjuvant arthritis. Immunology 1992 77 449-455.
6. López-Calderón A, Soto L & Martín AI. Chronic inflammation inhibits GH secretion and alters the serum insulin-like growth factor system in rats. Life Sciences 1999 65 2049-2060.
7. Tempi E, Koeller M, Riedl M, Wagner O, Graninger W & Luger A. Anterior pituitary function in patients with newly diagnosed rheumatoid arthritis. British Journal of Rheumatology 1996 35 350-556.
8. Demir H, Kelestimur F, Tune M, Kirnap M & Ozügüi Y. Hypothalamo-pituitary-adrenal axis and growth hormone axis in patients with rheumatoid arthritis. Scandinavian Journal of Rheumatology 1999 28 41-46.
9. Ibáñez de Cáceres I, Villanúa MA, Soto L, Martín I & López-Calderón A. IGF-I and IGF-I-binding proteins in rats with adjuvant-induced arthritis given recombinant human growth hormone. Journal of Endocrinology 2000 165 537-544.
10. Davies UM, Rooney M, Preece MA, Ansell BM & Woo P. Treatment of growth retardation in juvenile chronic arthritis with recombinant human growth hormone. Journal of Rheumatology 1994 21 153-158.
11. Touati G, Prieur AM, Ruiz JC, Noel M & Czernichow P. Beneficial effects of one-year growth hormone administration to children with juvenile chronic arthritis on chronic steroid therapy. I. Effects on growth velocity and body composition. Journal of Clinical Endocrinology and Metabolism 1998 83 403-409.
12. Dahn MS, Lange MP & Jacobs LA. Insulin-like growth factor-I production is inhibited in human sepsis. Archives of Surgery 1988 123 1409-1414.
13. Defalque D, Brandt N, Ketelslegers J-M & Thissen J-P. GH insensitivity induced by endotoxin injection is associated with decreased liver receptors. American Journal of Physiology 1999 276 E565-E572.
14. Tanaka H, Ueta Y, Yamashita U, Kannan H & Yamashita H. Biphasic changes in behavioral, endocrine, and sympathetic systems in adjuvant arthritis in Lewis rats. Brain Research Bulletin 1996 39 33-37.
15. Torres-Aleman I, Pons S & Santos-Benito FF. Survival of Purkinje cells in cerebellar cultures is increased by insulin-growth factor I. European Journal of Neuroscience 1992 4 864-869.
16. Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of proteins utilizing the principle of protein-dye binding. Analytical Biochemistry 1976 72 248-254.
17. Roberts CT, Lasky SR, Lowe WL, Seaman WT & LeRoith D. Molecular cloning of rat insulin-like growth factor I complementary deoxyribonucleic acids: differential messenger ribonucleic acid processing and regulation by growth hormone in extra-hepatic tissues. Molecular Endocrinology 1987 1 243-248.
18. Baumbach WR, Horner DL & Logan JS. The growth hormone-binding protein in rat serum is an alternatively spliced form of the rat growth hormone receptor. Genes and Development 1989 3 1199-1205.
19. Saphiro B, Waligora K & Pimstone BL. Generation of somatomedin activity in response to growth hormone and insulin from isolated perfused livers of normal and protein-malnourished rats. Journal of Endocrinology 1978 79 369-373.
20. Banu MJ, Orhii PB, Mejia W, McCarter RJ, Mosekilde L, Thomsen JS et al. Analysis of the effects of growth hormone, voluntary exercise, and food restriction on diaphyseal bone in female F344 rats. Bone 1999 25 469-480.
21. Gautsch TA, Kandl SM, Donovan SM & Layman DK. Response of the IGF-I system to prolonged undernutrition and its involvement in somatic and skeletal muscle growth retardation in rats. Growth Development and Aging 1998 62 13-25.
22. Liao W, Rudling M & Angelin B. Contrasting effects of growth hormone and insulin growth factor-1 on the biological activities of endotoxin in the rat. Endocrinology 1997 138 289-295.
23. Mao Y, Ling P-R, Fizgibbons TP, McCowen K, Frick GP, Bistrian BR et al. Endotoxin-induced inhibition of growth hormone receptor signaling in rat liver in vivo. Endocrinology 1999 140 5505-5515.
24. Davies UM, Jones J, Reeve J, Camacho-Hubner C, Charlett A, Ansell BM et al. Juvenile rheumatoid arthritis. Effects of disease activity and recombinant human growth hormone on insulin-like growth factor 1, insulin-like growth factor binding proteins 1 and 3, and osteocalcin. Arthritis and Rheumatism 1997 40 332-340.
25. Tsatsoulis A, Siamopoulou A, Petsoukis C, Challa A, Bairaktari E & Seferiadis K. Study of growth hormone secretion and action in growth-retarded children with juvenile chronic arthritis. Growth Hormone and IGF Research 1999 9 143-149.
26. Gabrielsson BG, Carminagnac DF, Flavell DM & Robinson ICAF. Steroid regulation of growth hormone (GH) receptor and GH-binding protein messenger ribonucleic acids in the rat. Endocrinology 1995 136 209-217.
27. Beauloye V, Ketelslegers JM, Moreau B & Thissen JP. Dexamethasone inhibits both growth hormone (GH)-induction of insulin-like growth factor-I (IGF-I) mRNA and GH receptor (GHR) mRNA levels in rat primary cultured hepatocytes. Growth Hormone and IGF Research 1999 9 205-211.
28. Simon D, Touati G, Prieur AM, Ruiz JC & Czernichow P. Growth hormone treatment of short stature and metabolic dysfunction in juvenile chronic arthritis. Acta Paediatrica 428 (Suppl 88) 1999 100-105.
29. Liao W, Rudling M & Angelin B. Growth hormone potentiates the in vivo biological activities of endotoxin in the rat. European Journal of Clinical Investigation 1996 26 254-258.
30. Takala J, Ruokonen E, Webster NR, Nielsen MS, Zandstra DF, Vundelinckx G et al. Increased mortality associated with growth hormone treatment in critically ill adults. New England Journal of Medicine 1999 341 785-792.
31. Van den Berghe G. Novel insights into the neuroendocrinology of critical illness. European Journal of Endocrinology 2000 143 1-13.
32. Hermansson M, Wickelgren RB, Hammerqvist F, Bjarnason R, Wennstrom I, Wernerman J et al. Measurement of human growth hormone receptor messenger ribonucleic acid by a quantitative polymerase chain reaction-based assay: demonstration of reduced expression after selective surgery. Journal of Clinical Endocrinology and Metabolism 1997 82 421-428.
33. Van den Berhe G, Baxter RC, Weekers F, Wouters P, Bowers CY & Veldehuis JD. A paradoxical gender dissociation within the growth hormone/insulin growth factor I axis during protracted critical illness. Journal of Clinical Endocrinology and Metabolism 2000 85 183-192.
34. Van den Berghe G, Wouters P, Weekers F, Mohan S, Baxter RC, Veldhuis JD et al. Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone releasing peptide and thyrotropin-releasing hormone in patients with protected critically illness. Journal of Clinical Endocrinology and Metabolism 1999 84 1311-1323.